Aplastic anemia with high reticulocytes suggests that the condition may be improving, and the treatment of aplastic anemia can be continued, including drug therapy and hematopoietic stem cell transplantation. 1. Aplastic anemia is caused by bone marrow hematopoietic failure, which is mainly manifested as low hematopoietic function of bone marrow and decrease of whole blood cells, causing anemia, bleeding and other symptoms. Reticulocytes are red blood cells that have not yet fully matured, which will be significantly reduced in aplastic anemia. Therefore, when the reticulocytes increase, it suggests that the bone marrow hematopoiesis is more active and the condition may be improving. 2. At this time, the treatment of aplastic anemia can be continued, commonly used drugs include immunosuppressants (such as cyclosporine, etc.), androgens (such as stanozolol, etc.), immunomodulators (levamisole, etc.); hematopoietic stem cell transplantation is also available. Aplastic anemia patients are recommended to go to the hospital, under the guidance of the physician early formal treatment.